U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06970847) titled 'The Aim for This Study is to Investigate the Ability of 64Cu-SAR-bisPSMA PET/CT to Detect Recurrence of Prostate Cancer' on April 29.
Brief Summary: The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer
Study Start Date: May 31
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Prostate Cancer Patients With Detectable PSA Following Prostatectomy
Prostate Cancer Recurrent
Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Prostate Cancer Patients Treated by Radiotherapy
Cryotherapy
Intervention:
DRUG: 64Cu-SAR-bisPSMA
All Patients will receive a sing...